Related Experiment Video
Updated: Jul 11, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Diagnosis and Management of Tuberculous Meningitis in Children- an Update
Ronald van Toorn1, Regan Solomons1
1Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Insights
Tuberculous meningitis (TBM) is a severe condition often missed due to vague symptoms. Early diagnosis and treatment are crucial for better outcomes in children, with short intensified therapy proving safe and effective.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Global Health
Background:
- Tuberculous meningitis (TBM) is a severe form of tuberculosis with significant neurological sequelae, particularly in resource-poor settings.
- Diagnosis is challenging due to nonspecific symptoms and suboptimal diagnostic tests, leading to delayed or missed cases.
- TBM remains a major cause of neurological disability and death in children worldwide.
Purpose of the Study:
- To provide an update on the current diagnosis and management strategies for tuberculous meningitis in children.
- To highlight the importance of early detection and intervention for improving patient outcomes.
- To discuss recent advancements and considerations in TBM treatment protocols.
Main Methods:
- Review of current literature and clinical guidelines on TBM diagnosis and management.
- Emphasis on clinical evaluation, history taking, and relevant investigations in resource-limited settings.
- Discussion of treatment strategies including short intensified therapy, management of hydrocephalus, and adjunctive therapies.
Main Results:
- Early diagnosis and prompt treatment are the most critical factors influencing outcomes in TBM.
- Short intensified treatment regimens are safe and effective for both HIV-infected and HIV-uninfected children.
- Corticosteroids improve outcomes in HIV-uninfected children, while thalidomide may benefit specific complications like abscesses.
Conclusions:
- Accurate and affordable diagnostic tests for TBM are a priority for resource-poor countries.
- Home-based TBM treatment is feasible for selected patients after initial hospital stabilization.
- Integrated management approaches, including early diagnosis, appropriate treatment, and supportive care, are essential for reducing TBM-related morbidity and mortality in children.
Abstract:
UPDATE ON THE DIAGNOSIS AND MANAGEMENT OF TUBERCULOUS MENINGITIS IN CHILDREN: Ronald van Toorn, Regan Solomons Seminars in Pediatric Neurology Volume 21, Issue 1, March 2014, Pages 12-18 Tuberculous meningitis (TBM), the most devastating manifestation of tuberculosis, is often missed or overlooked because of nonspecific symptoms and difficulties in diagnosis. It continues to be an important cause of neurologic handicap in resource-poor countries. Owing to the suboptimal performance of diagnostic tests of TBM, diagnosis relies on thorough history, clinical examination, and relevant investigations. The development of affordable, accurate diagnostic tests for TBM in resource-poor settings remains a priority. Short intensified treatment is safe and effective in both human immunodeficiency virus (HIV)-infected and HIV-uninfected children. Treatment of tuberculous hydrocephalus depends on the level of the cerebrospinal fluid obstruction. Corticosteroids reduce risk of neurodisability and death in HIV-uninfected children. Thalidomide should be considered in children compromised by tuberculosis abscesses and tuberculous-related optochiasmic arachnoiditis. In resource-poor countries, home-based TBM treatment after initial in-hospital stabilization is feasible in carefully selected patients. Early diagnosis and treatment of TBM is the single most important factor determining outcome.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tonsillitis II: Management